1. Introduction {#sec0001}
===============

Some viruses infect hosts over a range of temperatures depending on the host species. Most notable are the arboviruses which may infect the arthropod vector over a range of ambient temperatures from \~15 °C to \>30 °C ([@bib0040]), and then infect a vertebrate host at temperatures from 37 °C up to 44 °C in the case of West Nile virus (WNV) in infected American crows (*Corvus brachyrhynchos*) ([@bib0030]). Birds generally have higher body temperatures than mammals ([@bib0005]) and the avian influenza virus (AIV) when jumping from birds to humans has to adapt to a temperature drop of 8 °C since the temperature in the human upper respiratory tract is \~33 °C compared to \~41 °C in the avian intestinal tract which is the site of replication of avian viruses ([@bib0012]). Bats have higher core body temperatures than primates (up to 42.1 °C for *Phyllostomus hastatus* which is an omnivorous bat from South America) when flying ([@bib0045]). The core body temperature during flight of the insectivorous free-tailed bat (*Mops condylurus*) which may have been the origin of the 2013/15 severe *Zaire ebolavirus* (EBOV) outbreak in West Africa ([@bib0046]) is 40.5 °*C* ± 1 °C ([@bib0045]). Thus EBOV which infects a range of vertebrate species from bats to primates and deer may have to infect mammalian hosts over a range of temperatures. Similarly Nipah virus on jumping from fruit bats to pigs and humans ([@bib0011]) may experience a small fall in temperature. Furthermore, cross-species transmission of viruses to bats (and other mammals) from invertebrates may occur with more regularity than has been appreciated ([@bib0003]; [@bib0033]), and [@bib0003] have suggested that arthropods may host many "bat-associated" viruses that have defied detection in bats themselves (e.g. EBOV). Depending on the ambient temperature, viruses in arthropods would experience a 9 °C to 15 °C temperature increase on being ingested by a bat at 41 °C ([@bib0020]) and this could affect the binding affinity of the virus to its host cell depending on the thermodynamics of virus binding as is discussed here. In contrast other viruses only infect related host species, and in effect are maintained at similar temperatures. For example, simian immunodeficiency viruses (SIV) infect 36 different nonhuman primate species in sub-Saharan Africa and SIVs from chimpanzees (*Pan troglodytes*) have crossed species barriers on multiple occasions generating human immunodeficiency virus (HIV) types 1 and 2 ([@bib0047]). Thus the main source of temperature variation experienced by SIV and HIV would be the effect of the circadian rhythm and the slight rise in temperature due to infection of the host which gives a range of 36 °C to 38 °C in the case of Rhesus monkeys ([@bib0028]).

Viruses bind to host cells through interactions between a virus surface (glyco)protein (GP) and a host cell receptor (Cr). The Cr molecule on the cell surface may be a protein as in the case of HIV ([@bib0041]), EBOV ([@bib0053]), Hendra virus ([@bib0051]) and MERS-CoV ([@bib0036]) or alternatively is a sialic acid (SA) on a glycan as in the case of AIV ([@bib0012]; [@bib0018]) and arboviruses such as bluetongue virus (BTV) ([@bib0054]). The thermodynamics of virus binding in terms of the changes in enthalpy (ΔH~a_receptor_T~) and entropy (ΔS~a_receptor_T~) on the specific interaction of the GP with the Cr receptor at temperature T during binding of virus to the host cell surface has been set out previously ([@bib0021], [@bib0022]). The interactions between the HIV GP and its CD4 cellular receptor ([@bib0041]; [@bib0013]) and between the AIV haemagglutinin (HA) and its α2,3-SA or α2,6-SA receptors ([@bib0018]) are enthalpy driven, i.e. large negative values of ΔH~a_receptor_T~ overcome unfavourable values of ΔS~a_receptor_T~. Also the binding of vesicular stomatitis virus to phospholipid bilayers is enthalpy driven ([@bib0009]) with very large negative values of ΔH~a_receptor_T~.

Temperature may impose constraints on viruses' jumping the species barrier through its effect on the binding affinity of GP to Cr. There may also be constraints on the activities of viral replication proteins such as the AIV polymerase which showed a significantly higher activity at 33 °C than 37 °C ([@bib0043]). Only virus binding is considered here. Thus according to the Van\'t Hoff Isochore, the binding affinity for a virus to its host cell at temperature T as represented by the association constant K~a_virus_T~ would be greatly diminished for enthalpy-driven GP/Cr interactions at higher temperatures compared to lower temperatures depending on the magnitude of ΔH~a_receptor_T~ ([@bib0022]). Indeed, assuming ΔH~a_receptor_T~ is constant over the temperature range, the more negative ΔH~a_receptor_T~ is in magnitude, the weaker the binding at higher temperatures. This presents a paradox if the K~a_virus_T~ falls to less than \~10^14^ M^−^ ^1^ in that higher temperatures would greatly diminish infectivity ([@bib0022]).

While the values of ΔH~a_receptor_T~ and ΔS~a_receptor_T~ may be constant over the biological temperature range for some GP/Cr systems, e.g. AIV haemagglutinin (HA) binding to sialic acid (SA) residues ([@bib0018]) they may change considerably in magnitude over the biologically relevant temperature range particularly for protein:protein systems as in the case of HIV gp120 binding to CD4 ([@bib0041]) ([Fig. 1](#fig0001){ref-type="fig"} ). The effect of this on K~a_virus_T~ is considered in this work. The change in ΔH~a_receptor_T~ with temperature is defined by the difference in heat capacities (C~p~) of the GP/Cr "product" complex and the free GP/free host Cr "reactants" and is represented by ΔC~p~ which is the slope of the lines in [Fig. 1](#fig0001){ref-type="fig"} and typically ranges from \~0 kJ/mol/K to −5.0 kJ/mol/K depending on the system.Fig. 1Variation in ΔH~a_receptor_T~ as a function of temperature as reported for HIV gp120 monomer binding to CD4 (○) ([@bib0041]) and AIV HA monomer binding to soluble α2--6 sialyllactose (Δ) and α2--3 sialyllactose (□) ([@bib0018]). The slopes of the lines represent the ΔC~p~ values which are summarised in [Table 3](#tbl0003){ref-type="table"}.Fig. 1:

The previous thermodynamic treatment of virus binding ([@bib0022]) identified the entropy change (ΔS~a_immob~) on immobilisation of the whole virus particle on the host cell surface as a key parameter for which there are currently no data. ΔS~a_immob~ would be expected to be large and negative in magnitude due to the decrease in the absolute entropy on immobilisation of a large molecular entity such as a virion. A recent analysis has shown that virion volume (and genome length) for dsDNA viruses decreases by about 55-fold as the temperature of occurrence (i.e. host) increases from 0 to 40 °C ([@bib0044]). The temperature of occurrence in these dsDNA viruses ranges from near zero for those inhabiting polar environments to over 40 °C for those inhabiting endothermic vertebrates. [@bib0044] suggest that this could reflect smaller viruses being able to replicate more quickly (due to more compact genomes) perhaps together with energetic constraints imposed by their hosts. However from the thermodynamic perspective, the decrease in volume and hence mass and radius of the virus will make ΔS~a_immob~ less negative for a smaller virus than for a larger virus. It is shown here how a less negative ΔS~a_immob~ increases binding of the virus at the relatively high mammalian body temperatures and it is proposed that thermodynamic binding constraints may give smaller viruses a selective advantage for infecting hosts at the higher body temperatures of mammals and birds. In this respect, the large size of the HIV virion may present a constraint to binding at human body temperatures compared to the much smaller arboviruses for example.

In the case of HIV, the GP component of the GP/Cr interaction is the envelope protein (Env) which is a trimer of gp120 monomers. Each HIV Env trimer interacts with one CD4 molecule ([@bib0010]; [@bib0034]). This is different from the AIV HA trimer in which each monomer in the trimer interacts with one glycan Cr ([@bib0012]; [@bib0018]). Initial attachment of the HIV virion to the host CD4^+^ *T* cell surface is relatively nonspecific ([@bib0049]) with HIV Env interacting with negatively charged host cell surface heparan sulphate proteoglycans, or with pattern recognition receptors. According to [@bib0049], non-specific HIV attachment to the host cell via any of these factors likely brings HIV Env into close proximity with the viral receptor CD4 and the CRR5 coreceptor, so increasing the efficiency of infection, although the physiologic role of non-specific attachment in vivo remains unclear. Here it is suggested that non-specific binding helps to overcome the thermodynamic entropy constraint of immobilisation of a large virus on binding at human body temperature by taking some of the entropy loss in ΔS~a_immob~ prior to specific HIV Env:CD4 binding. This would be consistent with the fact that non-specific attachment factors differ from receptors in that they are not essential, although they augment infection in vitro ([@bib0049]).

A review of the literature has not found any results for the effect of temperature on the binding of HIV to CD4^+^ *T* cells with which to test or validate the HIV thermodynamic binding model developed here. However, [@bib0019] reported the binding of cells expressing HIV GP on their surface to CD4^+^ *T* cells over the temperature range of 0 °C to 42 °C. It is known that increasing host membrane fluidity at higher temperature allows effective recruitment of more Cr molecules to bind the HIV virion ([@bib0024]) such that the number, n, of GP/Cr contacts increases with temperature ([@bib0019]), and that increasing n can overcome both the effect of temperature on decreasing the GP/Cr binding affinity and the effect of a large negative ΔS~a_immob~ ([@bib0022]). The thermodynamic HIV binding model here is therefore modified to accommodate increasing n with temperature and so attempt to reproduce the results of [@bib0019]. The success of the model here is in predicting the subsequent decrease in binding reported by [@bib0019] at higher temperatures due to ΔS~a_immob~.

Here six case studies are presented to illustrate the effects of the magnitude of n, ΔC~p~ and ΔS~a_immob~ on the temperature sensitivity of virus binding. These are:-1The predicted effect of the magnitude of ΔC~p~ on the temperature dependence of Dengue virus (DENV) transmission by *Aedes albopictus*;2The predicted effect of the magnitude of ΔC~p~ on the temperature peak observed for the specific binding of Western equine encephalitis virus (WEEV) to susceptible *Culex tarsalis* brush border fragments (BBFs);3A large negative ΔC~p~ for a protein:protein GP/Cr system as represented by HIV gp120:CD4 diminishes host cell binding at human body temperature;4A large virus diameter as for the HIV virion diminishes host cell binding at the higher temperature of the human body through the large negative ΔS~a_immob~;5Non-specific attachment factors may partially overcome the unfavourable ΔS~a_immob~ and hence enhance specific HIV binding through Env:CD4 interactions at human body temperature; and6Increasing the number, n, of GP/Cr contacts with temperature to reproduce the data of [@bib0019] for binding of HIV Env-expressing cells to cells expressing CD4.

It may be thought there is little point in modelling HIV binding with temperature because HIV only infects human hosts at \~37 °C. However, the model here suggests mammalian temperature may be a constraint on HIV binding (due to the large negative ΔC~p~ and ΔS~a_immob~) in effect exposing a potential weakness in the HIV infection process which could be exploited for antiviral therapy. The implications of making ΔS~a_immob~ more negative are considered here as a novel approach to developing antiviral therapies with reference to [@bib0001] using zinc oxide nanoparticles for preventing infection by herpes simplex virus type 2 (HSV-2).

2. Methods {#sec0002}
==========

2.1. The change in heat capacity (ΔC~p~) on binding of virus GP to Cr receptors on the host cell {#sec0003}
------------------------------------------------------------------------------------------------

The change in enthalpy (H) with temperature (T) at constant pressure is the heat capacity, C~p~.$$\left( \frac{\partial H}{\partial T} \right)_{p} = C_{p}$$

Integrating with respect to temperature relates the absolute enthalpy (H~T~) at temperature T to that (H~T0~) at a given reference temperature T~0~ through C~p~ according to [Eq. (1)](#eqn0001){ref-type="disp-formula"} (see [Table 1](#tbl0001){ref-type="table"} ). The attachment of a virus to its host cell is driven by the n individual interactions between GP and Cr made on binding as represented by the dynamic equilibrium in [Eq. (2)](#eqn0002){ref-type="disp-formula"}. The change in enthalpy for GP binding to Cr at temperature T, ΔH~a_receptor_T~, is given by [Eq. (3)](#eqn0003){ref-type="disp-formula"}.Table 1Equations used. See methods for derivation.Table 1$$\mathbf{H}_{\mathbf{T}} = \mathbf{H}_{\mathbf{T}_{0}} + \mathbf{C}_{\mathbf{p}}\left( {\mathbf{T} - \mathbf{T}_{0}} \right)$$$$\left. \text{GP} + \text{Cr}\leftrightarrow\text{GP}.\text{Cr} \right.$$$$\Delta\mathbf{H}_{\mathbf{a}\_\mathbf{receptor}\_\mathbf{T}} = \mathbf{H}_{\mathbf{T}}\left( {\mathbf{GP} \cdot \mathbf{Cr}} \right) - \left( {\mathbf{H}_{\mathbf{T}}\left( \mathbf{GP} \right) + \mathbf{H}_{\mathbf{T}}\left( \mathbf{Cr} \right)} \right)$$$$\Delta\mathbf{H}_{\mathbf{a}\_\mathbf{receptor}\_\mathbf{T}} = \Delta\mathbf{H}_{\mathbf{a}\_\mathbf{receptor}\_\mathbf{T}_{0}} + \Delta\mathbf{C}_{\mathbf{p}}\left( {\mathbf{T} - \mathbf{T}_{0}} \right)$$$$\Delta\mathbf{C}_{\mathbf{p}} = \mathbf{C}_{\mathbf{p}}\left( {\mathbf{GP} \cdot \mathbf{Cr}} \right) - \left( {\mathbf{C}_{\mathbf{p}}\left( \mathbf{GP} \right) + \mathbf{C}_{\mathbf{p}}\left( \mathbf{Cr} \right)} \right)$$$$\Delta\mathbf{S}_{\mathbf{a}\_\mathbf{receptor}\_\mathbf{T}} = \Delta\mathbf{S}_{\mathbf{a}\_\mathbf{receptor}\_\mathbf{T}_{0}} + \Delta\mathbf{C}_{\mathbf{p}}\mathbf{\ln}\frac{\mathbf{T}}{\mathbf{T}_{0}}$$$$\Delta H_{a\_\text{virus}\_ T} = n\mspace{6mu} \times \Delta H_{a\_\text{receptor}\_ T}$$$$\Delta S_{a\_\text{virus}\_ T} = \Delta S_{a\_\text{immob}} + n\mspace{6mu} \times \mspace{6mu}\Delta S_{a\_\text{receptor}\_ T}$$$$\Delta G_{a\_\text{virus}\_ T} = \Delta H_{a\_\text{virus}\_ T} - T\Delta S_{a\_\text{virus}\_ T}$$$$\Delta\mathbf{G}_{\mathbf{a}\_\mathbf{virus}\_\mathbf{T}} = \mathbf{n}\Delta\mathbf{H}_{\mathbf{a}\_\mathbf{receptor}\_\mathbf{T}} - \mathbf{nT}\Delta\mathbf{S}_{\mathbf{a}_{\mathbf{receptor}\__{\mathbf{T}}}} - \mathbf{T}\Delta\mathbf{S}_{\mathbf{a}\_\mathbf{immob}}$$$$\Delta\mathbf{G}_{\mathbf{a}\_\mathbf{virus}\_\mathbf{T}} = \mathbf{n}\Delta\mathbf{H}_{\mathbf{a}\_\mathbf{receptor}\_\mathbf{T}_{0}} - \mathbf{nT}\Delta\mathbf{S}_{\mathbf{a}\_\mathbf{receptor}\_\mathbf{T}_{0}} + \mathbf{n}\Delta\mathbf{C}_{\mathbf{p}}\left( {\mathbf{T} - \mathbf{T}_{0} - \mathbf{Tln}\frac{\mathbf{T}}{\mathbf{T}_{0}}} \right) - \mathbf{T}\Delta\mathbf{S}_{\mathbf{a}\_\mathbf{immob}}$$$$\mathbf{K}_{\mathbf{a}\_\mathbf{virus}\_\mathbf{T}} = \mathbf{\exp}\left( \frac{- \Delta\mathbf{G}_{\mathbf{a}\_\mathbf{virus}\_\mathbf{T}}}{\mathbf{RT}} \right)$$$$\mathbf{F}_{\mathbf{cT}} = \frac{\left\lbrack \mathbf{V}_{\mathbf{free}} \right\rbrack}{\left\lbrack \mathbf{V}_{\mathbf{free}} \right\rbrack + {1\!/\!\mathbf{K}_{\mathbf{a}\_\mathbf{virus}\_\mathbf{T}}}}$$$$\mathbf{C}.\mathbf{V}_{\mathbf{T}} = \mathbf{F}_{\mathbf{cT}} \times \mathbf{C}_{\mathbf{total}}$$$$\mathbf{p}_{\mathbf{completeT}} = \mathbf{p}_{\mathbf{complete}283} \times \mathbf{e}^{({\frac{\mathbf{E}_{\mathbf{A}}}{\mathbf{R}} \times {({\frac{1}{283} - \frac{1}{\mathbf{T}}})}})}$$$$\mathbf{p}_{\mathbf{transmissionT}} = 1 - \left( {1 - \mathbf{p}_{\mathbf{completeT}}} \right)^{\mathbf{C}.\mathbf{V}_{\mathbf{T}}}$$$$\mathbf{K}_{\mathbf{a}\_\mathbf{virus}\_\mathbf{T}} = \frac{1}{\left( \mathbf{K}_{\mathbf{d}\_\mathbf{receptor}\_\mathbf{T}} \right)^{\mathbf{n}}} \times \mathbf{e}^{\frac{\Delta\mathbf{S}_{\mathbf{a}\_\mathbf{immo}\mathbf{b}}}{\mathbf{R}}}$$$$\Delta\mathbf{S}_{\mathbf{a}\_\mathbf{immob}} \propto - \mathbf{\ln}\left( {\frac{4}{3}\mathbf{\pi}\mathbf{r}^{3}} \right) - 3\mathbf{\ln}\left( {\left( {\frac{4}{3}\mathbf{\pi}\mathbf{r}^{3}} \right)\mathbf{r}^{2}} \right)$$$$\Delta\mathbf{S}_{\mathbf{a}\_\mathbf{specific}} = \Delta\mathbf{S}_{\mathbf{a}\_\mathbf{immob}} - \Delta\mathbf{S}_{\mathbf{a}\_\mathbf{non}\_\mathbf{specific}}$$

Substituting [Eq. (1)](#eqn0001){ref-type="disp-formula"} into [Eq. (3)](#eqn0003){ref-type="disp-formula"} for the enthalpies for the GP.Cr complex (H~T~(GP.Cr)), the free GP (H~T~(GP)) and the free Cr (H~T~(Cr)) relates the enthalpy change for GP binding to Cr at temperature T, ΔH~a_receptor_T~, to that (ΔH~a_receptor_T0~) measured experimentally at temperature T~0~ ([@bib0016]) according to [Eq. (4)](#eqn0004){ref-type="disp-formula"} where ΔC~p~ is the change in heat capacity defined as the difference between the heat capacities of the GP.Cr complex and the sum of the heat capacities of the free GP and Cr molecules as given by [Eq. (5)](#eqn0005){ref-type="disp-formula"}. Similarly the entropy change (ΔS~a_receptor_T~) for GP binding to Cr at temperature T is related to that (ΔS~a_receptor_T0~) measured experimentally at temperature T~0~ ([@bib0016]) according to [Eq. (6)](#eqn0006){ref-type="disp-formula"}.

2.2. Modelling the effect of temperature on ΔH~a_virus_T~ and ΔS~a_virus_T~ and hence K~a_virus\_T~ {#sec0004}
---------------------------------------------------------------------------------------------------

ΔH~a_virus_T~ and ΔS~a_virus_T~ are the changes in enthalpy and entropy respectively on binding of virus to host cell at temperature T. Substituting the terms for ΔH~a_virus_T~ ([Eq. (7)](#eqn0007){ref-type="disp-formula"}) and ΔS~a_virus_T~ ([Eq. (8)](#eqn0008){ref-type="disp-formula"}) into [Eq. (9)](#eqn0009){ref-type="disp-formula"} expresses ΔG~a_virus_T~ in terms of n, ΔS~a_immob~, ΔH~a_receptor_T~ and ΔS~a_receptor_T~ ([Eq. (10)](#eqn0010){ref-type="disp-formula"}) where ΔG~a_virus_T~ is the change in Gibbs free energy on association of virus with a host cell at temperature T and ΔS~a_immob~ is the change in entropy on immobilisation of the whole virus on the cell surface ([@bib0021]; [@bib0022]).

### 2.2.1. The change in heat capacity on virus binding to its host cell {#sec0005}

For this work it is assumed that the change in heat capacity on binding of a virus to a host cell is determined by the change in heat capacity on interaction of GP with Cr according to [Eq. (5)](#eqn0005){ref-type="disp-formula"} and that ΔS~a_immob~ in [Eq. (10)](#eqn0010){ref-type="disp-formula"} is unaffected. In effect therefore the heat capacity of the "bulk" (i.e. non-GP/Cr) of the bound virus/host cell is the same as the sum of the heat capacities for the free virus and free host cell. This is acceptable because a change in heat capacity is related to a change in conformation of the molecular components ([@bib0041]) and the conformation of the bulk of the host cell and the virus would be unaffected by attachment. Indeed, ΔS~a_immob~ is mainly related to changes in rotational and translational mobility of the virus particle as a whole (see below) and does not involve the conformational changes in GP and Cr which are accommodated in the ΔS~a_receptor_T~ term ([@bib0022]). Since the heat capacity of the "bulk" of the bound virus/host cell is the same as the sum of the heat capacities for the free virus and free host cell, ΔC~p~ for the bulk equals zero, and according to [Eq. (6)](#eqn0006){ref-type="disp-formula"} therefore, ΔS~a_immob~ itself at temperature T (calculated as ΔS~a_immob_T~ = ΔS~a_immob_T0~ + ΔC~p~.ln(T/T~0~)) would be unaffected by temperature and hence constant as assumed in the models here.

### 2.2.2. The effect of the magnitude of ΔC~p~ on virus binding affinity at temperature T {#sec0006}

Substituting ΔH~a_receptor_T~ and ΔS~a_receptor_T~ from [Eqs. (4)](#eqn0004){ref-type="disp-formula"} and [(6)](#eqn0006){ref-type="disp-formula"} respectively into [Eq. (10)](#eqn0010){ref-type="disp-formula"} gives [Eq. (11)](#eqn0011){ref-type="disp-formula"} from which K~a_virus_T~ is calculated according to [Eq. (12)](#eqn0012){ref-type="disp-formula"} where R is the ideal gas constant.

### 2.2.3. The choice of reference temperature, T~0~ {#sec0007}

Comparing the predicted effect on K~a_virus_T~ of the magnitude of ΔC~p~ in Case studies 1, 2 and 3 requires a reference temperature, T~0~, to be defined at which the plots of K~a_virus_T~ intercept. Values of K~a_virus_T~ intercept at *T* = T~0~ because the n.ΔC~p~ (T -- T~0~ + *T*.ln(T/T~0~)) term in [Eq. (11)](#eqn0011){ref-type="disp-formula"} equals zero. Therefore for the purpose of demonstrating the effect of ΔC~p~ on the temperature sensitivity of K~a_virus_T~, T~0~ needs to be chosen to be well above or below the temperature range of interest. It should be noted that the choice of reference temperature is artificial and is only used here out of necessity to demonstrate the effect of different ΔC~p~ values while fixing the K~a_virus_T~ intercept temperature. Indeed a given GP/Cr system has its own natural ΔC~p~ value which cannot be altered and is measured experimentally ([@bib0041]; [@bib0018]). The T~0~ temperature of 37 °C is appropriate to study arthropod vector competence for arbovirus transmission over the 10 to 35 °C temperature range in Case studies 1 and 2 as used previously for the arthropod vector competence model ([@bib0022]). However, since 37 °C is the human body temperature at which HIV binds to host cells, 37 °C is not a good choice for T~0~ in case study 3 for which T~0~ is therefore set to 4 °C. The reference temperature is 37 °C in Case studies 4, 5 and 6 because the experimentally measured value of ΔC~p~ for HIV gp120:CD4 binding ([Fig. 1](#fig0001){ref-type="fig"}) is used together with ΔH~a_receptor_T0~ and ΔS~a_receptor_T0~ values measured experimentally at a temperature T~0~ of 37 °C ([@bib0041]), i.e. real data are used.

2.3. Case study 1: The predicted effect of the magnitude of ΔC~p~ on the temperature dependence of DENV transmission by *Aedes albopictus* {#sec0008}
------------------------------------------------------------------------------------------------------------------------------------------

The approach for modelling arbovirus transmission efficiency by the arthropod vector has been fully described previously ([@bib0022]) and is summarised here for the purpose of the models in [Figs. 2](#fig0002){ref-type="fig"} and [3](#fig0003){ref-type="fig"} .Fig. 2Temperature variation of a) K~a_virus_T~; b) C.V~T~, c) and d) p~transmissionT~ for ΔC~p~ = 0 (solid line), −1.97 (dotted line) and −5.02 (dashed line) kJ/mol/K ([Table 3](#tbl0003){ref-type="table"}) with model parameters for arbovirus binding to mosquito midgut cells in [Table 2](#tbl0002){ref-type="table"} and ΔS~a_immob~ = 0 J/mol/K. Experimental data (■) in c) and d) for DENV transmission efficiency by *Aedes albopictus* mosquitoes from [@bib0035]Fig. 2:Fig. 3Temperature variation of a) K~a_virus_T~ and b) C.V~T~ for ΔC~p~ = 0 (solid line), −3.0 (dotted line) and −5.02 (dashed line) kJ/mol/K ([Table 3](#tbl0003){ref-type="table"}) with model parameters for arbovirus binding to mosquito midgut cells in [Table 2](#tbl0002){ref-type="table"} and ΔS~a_immob~ = 0 J/mol/K. Experimental data (■) in b) show specific binding (as the percentage of total virus bound) of Western equine encephalitis virus (WEEV) to brush border fragments from susceptible *Culex tarsalis* mosquitoes as determined by [@bib0027].Fig. 3:

### 2.3.1. Modelling K~a_virus\_T~ as a function of temperature {#sec0009}

The strength of GP/Cr binding at temperature T is often expressed as the dissociation constant, K~d_receptor_T~, for which smaller values indicate stronger binding ([@bib0050]). The thermodynamic model is based on an enthalpy-driven GP/Cr interaction with a K~d_receptor_T0~ of 10^−3^ M at 37 °C (T~0~) as used previously ([@bib0022]) to represent the interaction between an arbovirus GP and a SA glycan (Cr) on the brush border surface of the epithelial cells lining the arthropod midgut. The parameters ΔH~a_receptor_T0~ and ΔS~a_receptor_T0~ at T~0~ = 37 °C for DENV transmission by *Aedes albopictus* together with n and ΔS~a_immob~ are set out in [Table 2](#tbl0002){ref-type="table"} and values of K~a_virus_T~ over the temperature range 10--37 °C are calculated for the ΔC~p~ values in [Table 3](#tbl0003){ref-type="table"} using ΔG~a_virus_T~ from [Eq. (11)](#eqn0011){ref-type="disp-formula"} in [Eq. (12)](#eqn0012){ref-type="disp-formula"}.Table 2Summary of the parameters for the enthalpy-driven GP/Cr binding model for DENV transmission by *Aedes albopictus* developed previously ([@bib0022]).Table 2ParameterValueReplication kinetic parameters for [Eq. (15)](#eqn0015){ref-type="disp-formula"}p~complete283~ (10 °C)8.0 × 10^−7^E~A~ (kJ/mol)270.0GP/Cr binding parametersΔH~a_receptor_T0~ at 37 °C (kJ/mol)−56.545ΔS~a_receptor_T0~ at 37 °C (J/mol/K)−125K~d_receptor_T0~ at 37 °C10^−3^ MWhole virus binding parametersΔS~a_immob~ (J/mol/K)0Number of GP/Cr contacts (n)4ΔH~a_virus_T0~ (kJ/mol) from [Eq. (7)](#eqn0007){ref-type="disp-formula"}−226.2ΔS~a_virus_T0~ (J/mol/K) from [Eq. (8)](#eqn0008){ref-type="disp-formula"}−500Table 3Summary of some published ΔC~p~ values for protein/protein and protein/sialic acid (SA) interactions.Table 3SystemK~d_receptor_T~ (Temperature)ΔC~p~ kJ/mol/K (95% c.i.)Temperature range of experimentReferencesHIV gp120 monomer: CD45 × 10^−9^ M (37 °C)−5.02 (± 0.84)12 to 44 °C[@bib0041]E3 in pyruvate dehydrogenase multienzyme complex6 × 10^−10^ M (25 °C)−1.32 (±0.06)10 to 37 °C[@bib0029]E1 in pyruvate dehydrogenase multienzyme complex3 × 10^−10^ M (25 °C)−1.97 (±0.06)10 to 37 °C[@bib0029]AIV HA monomer: SAα−2,64.8 × 10^−2^ M (25 °C)+0.125[\*](#tb3fn1){ref-type="table-fn"}15 to 25 °C[@bib0018]AIV HA monomer: SAα−2,32.6 × 10^−2^ M (25 °C)−0.0074[\*](#tb3fn1){ref-type="table-fn"}15 to 25 °C[@bib0018][^1]

### 2.3.2. Modelling the effect of temperature on the number of cells in the arthropod midgut with bound arbovirus {#sec0010}

The arbovirus challenge dose is 10^5^ virions and the midgut volume is 10^−6^ dm^3^ giving a virus concentration \[V~total~\] = 1.7 × 10^−13^ M. The fraction (F~cT~) of arthropod midgut cells with bound arbovirus at temperature T is calculated from K~a_virus_T~ using [Eq. (13)](#eqn0013){ref-type="disp-formula"} assuming the concentration of free virus (\[V*~free~*\]) \~ \[V~total~\]. The number, C.V~T~, of midgut cells with bound arbovirus at temperature T is calculated by multiplying F~cT~ by the total number of midgut cells (C~total~ = 1000) ([Eq. (14)](#eqn0014){ref-type="disp-formula"}) as described previously ([@bib0022]).

### 2.3.3. Modelling the effect of temperature on the arbovirus transmission efficiency {#sec0011}

The probability, p~completeT~, of an arthropod midgut cell with bound virus successfully leading to infection of the arthropod salivary glands and completion of virogenesis within in the lifetime of the arthropod at temperature T is calculated using the Arrhenius equation ([Eq. (15)](#eqn0015){ref-type="disp-formula"}) where p~complete283~ is the probability of this happening at 10 °C (283 K) and E~A~ is the activation energy of the rate-limiting step in virogenesis ([Table 2](#tbl0002){ref-type="table"}). The probability, p~transmissionT~, of arbovirus transmission by the arthropod (i.e. successful infection of the arthropod salivary glands after oral exposure) at temperature T given C.V~T~ midgut cells have bound virus is given by [Eq. (16)](#eqn0016){ref-type="disp-formula"}.

2.4. Case study 2: The magnitude of ΔC~p~ could explain the temperature peak observed in the specific binding of WEEV to susceptible *Culex tarsalis* BBFs {#sec0012}
----------------------------------------------------------------------------------------------------------------------------------------------------------

The value of ΔC~p~ in [Eq. (11)](#eqn0011){ref-type="disp-formula"} with the GP/Cr binding parameters for DENV in [Table 2](#tbl0002){ref-type="table"} was optimised so that C.V~T~ as a function of temperature best approximated the specific binding affinity of WEEV to BBFs from susceptible *Culex tarsalis* mosquitoes as determined by [@bib0027] and shown in [Fig. 3](#fig0003){ref-type="fig"}.

2.5. Case study 3: A large negative ΔC~p~ for a protein:protein GP/Cr system as represented by HIV gp120:CD4 diminishes host cell binding at higher temperatures {#sec0013}
----------------------------------------------------------------------------------------------------------------------------------------------------------------

### 2.5.1. Estimation of n for HIV {#sec0014}

[@bib0052] using defective HIV gp120 monomers concluded that a single Env trimer is sufficient to mediate the entry of one virion, but that all three gp120 monomers in that trimer must be active. [@bib0031] has proposed that a realistic model allows both a minimum requirement of two gp120 monomers with an increment in function by the third. This is consistent with the cryo-electron microscopy (EM) structure of the Env glycoprotein trimer ([@bib0034]) showing that in each trimer, one gp120 monomer makes a primary contact with the bound CD4 Cr molecule while a second makes a partial contact (called the quaternary contact reflecting protein structure nomenclature) and the third gp120 monomer makes no direct contact with the CD4 at all. For the purpose of the model here, n represents the number of Env trimers on each HIV virion that interact with a CD4 Cr during binding. [@bib0004] demonstrate that divergent HIV strains differ in their stoichiometry of entry and require between 1 and 7 Env trimers, with most strains depending on 2 to 3 Env trimers to complete infection. Here it is assumed that *n* = 3 Env:CD4 interactions for HIV binding although the results of [@bib0004] do not separate cell surface binding itself from the subsequent HIV/cell fusion in the entry process. If it is later found that cell surface binding only requires one Env:CD4 interaction for example, while more are required for the membrane fusion, then the model here for C.V~T~ should be re-parameterised with *n* = 1 although the number of Env:CCR5 and non-specific Env interactions with attachment factors (see below) should also be built into the model. It should be noted that as for the arbovirus model, it is assumed that the *n* = 3 Env:CD4 interactions act independently and not co-operatively in binding. This is reflected in [Eqs. (7)](#eqn0007){ref-type="disp-formula"} and [(8)](#eqn0008){ref-type="disp-formula"} where ΔH~a_receptor_T~ and ΔS~a_receptor_T~ act additively.

### 2.5.2. Thermodynamic parameters for HIV Env:CD4 binding at T~0~ of 37 °C {#sec0015}

The Env trimer binds a single soluble CD4 with a K~d_receptor_T~ (25 °C) of 1.4 × 10^−9^ M ([@bib0010]) which is 15-fold higher than that for the gp120 monomer:CD4 interaction estimated at 25 °C from the data of [@bib0041] in [Table 4](#tbl0004){ref-type="table"} . To the author\'s knowledge there are no data for ΔH~a_receptor_T~ and ΔS~a_receptor_T~ for Env trimer binding to CD4. Therefore the values for ΔH~a_receptor_T0~ and ΔS~a_receptor_T0~ for HIV gp120 monomer:CD4 binding at 37 °C from [@bib0041] are used for Env trimer binding to a single CD4 in the HIV model in [Fig. 4](#fig0004){ref-type="fig"} a and b as set out in [Table 4](#tbl0004){ref-type="table"}. [@bib0013] reported values at 37 °C of −287.9 kJ/mol and --786.9 J/mol/K for ΔH~a_receptor_T~ and ΔS~a_receptor_T~ respectively for the wildtype HIV-1 YU2 gp120 monomer binding to soluble CD4. The more negative ΔS~a_receptor_T~ value for gp120 monomer:CD4 binding from [@bib0013] reduces the binding affinity for gp120:CD4 by nine-fold (K~d_receptor\_~ *~T~* = 4.2 × 10^−8^ M) at 37 °C compared to that of 4.75 × 10^−9^ M from [@bib0041] ([Table 4](#tbl0004){ref-type="table"}). This difference may simply reflect the different strains of HIV-1 used, namely YU2 by [@bib0013] and WD61 by [@bib0041]. The HIV gp120 monomer:CD4 binding data of [@bib0041] are chosen here over those of [@bib0013] because [@bib0041] present the variation in ΔH~a_receptor_T~ with temperature as shown in [Fig. 1](#fig0001){ref-type="fig"} together with information on ΔC~p~ which [@bib0013] do not consider. It is therefore assumed here that ΔC~p~ = −5.02 kJ/mol/K for the Env trimer:CD4 interaction as reported by [@bib0041] for the gp120 monomer:CD4 interaction ([Table 3](#tbl0003){ref-type="table"}).Table 4Thermodynamic parameters for HIV Env binding to CD4 receptor at different temperatures. In the absence of data, the binding parameters for HIV Env trimer to CD4 as used in the models here are based on those from [@bib0041] for the full-length gp120 monomer binding to CD4.Table 437 °C4 °C25 °CΔH~a_receptor_T~ (kJ/mol)−263.59[a](#tb4fn1){ref-type="table-fn"}−97.9[c](#tb4fn3){ref-type="table-fn"}−198.2[e](#tb4fn5){ref-type="table-fn"}ΔS~a_receptor_T~ (J/mol/K)−691.04[b](#tb4fn2){ref-type="table-fn"}−126.01[d](#tb4fn4){ref-type="table-fn"}−472.9[e](#tb4fn5){ref-type="table-fn"}^,^[f](#tb4fn6){ref-type="table-fn"}K~d_receptor_T~ (M)4.75 × 10^−9^1.28 × 10^−12^[e](#tb4fn5){ref-type="table-fn"}0.91 × 10^−10^[^2][^3][^4][^5][^6][^7]Fig. 4Temperature variation of a) and c) K~a_virus_T~ and b) and d) number, C.V~T~, of CD4^+^*T* cells per mm^3^ blood with bound HIV virions in HIV model for ΔC~p~ = 0 (solid line), −1.97 (dotted line) and −5.02 (dashed line) kJ/mol/K ([Table 3](#tbl0003){ref-type="table"}) and thermodynamic parameters for *n* = 3 HIV Env:CD4 interactions in [Table 4](#tbl0004){ref-type="table"} at reference temperature a) and b) T~0~ = 37 °C; c) and d) T~0~ = 4 °C. ΔS~a_immob~ = −400 J/mol/K.Fig. 4:

Values of ΔS~a_receptor_T~ are not documented by [@bib0041] other than that at 37 °C ([Table 4](#tbl0004){ref-type="table"}) and values at lower temperatures are therefore calculated from that at T~0~ = 37 °C according to [Eq. (6)](#eqn0006){ref-type="disp-formula"} using ΔC~p~ = −5.02 kJ/mol/K for HIV gp120:CD4 ([Table 3](#tbl0003){ref-type="table"}). Some reassurance that [Eq. (6)](#eqn0006){ref-type="disp-formula"} is appropriate is that the value of ΔS~a_receptor_T~ of −493 J/mol/K predicted at *T* = 25 °C by [Eq. (6)](#eqn0006){ref-type="disp-formula"} is very close to that of −473 J/mol/K calculated from the --T. ΔS~a_receptor_T~ value reported by [@bib0041] at 25 °C ([Table 4](#tbl0004){ref-type="table"}).

### 2.5.3. Thermodynamic parameters for HIV Env:CD4 binding at T~0~ of 4 °C {#sec0016}

Predicted values for ΔH~a_receptor_T~ and ΔS~a_receptor_T~ for HIV Env:CD4 binding at 4 °C are set out in [Table 4](#tbl0004){ref-type="table"} and are used as ΔH~a_receptor_T0~ and ΔS~a_receptor_T0~ respectively for the HIV model in [Fig. 4](#fig0004){ref-type="fig"}c and d with the reference temperature, T~0~, set to 4 °C to assess the effect of varying ΔC~p~ on the temperature sensitivity of K~a_virus_T~ and C.V~T~ up to and above human body temperature.

### 2.5.4. Model for HIV binding to CD4^+^*T* cells in blood {#sec0017}

The 2.5 to 97.5 percentile range for the number of CD4^+^ *T* cells in humans is 448 to 1611 cells per mm^3^ (10^−6^ dm^3^) of blood with a mean of 919 cells per mm^3^ ([@bib0048]). The model here takes 1 mm^3^ of blood with C~total~ = 10^3^ CD4^+^ *T* cells and introduces V~total~ = 10^5^ HIV virions. Dividing 10^5^ HIV virions in 10^−6^ dm^3^ by the Avogadro number gives \[V~total~\] = 1.7 × 10^−13^ M. The advantage of using a high V~total~ that greatly exceeds C~total~ is that as previously demonstrated by [@bib0021] not only may the fraction, F~cT~, of CD4^+^ *T* cells with bound HIV be calculated from [Eq. (13)](#eqn0013){ref-type="disp-formula"} with \[V~free~\] \~ \[V~total~\] but also any complications of handling stochastic effects at low virus doses are avoided. It is recognised that the HIV concentration at 10^5^ HIV virions per mm^3^ used in this model is 10-fold to 100-fold higher than that expected in a recipient person\'s blood present in the capillaries lining the skin at the wound site where semen or blood from an infected source were introduced since maximum human plasma and human semen HIV loadings are in the region of 13,000 copies per mm^3^ and 1800 copies per mm^3^ respectively ([@bib0023]). This is not important, however, because the purpose of the models here in [Figs. 4](#fig0004){ref-type="fig"} [--6](#fig0006){ref-type="fig"} is not to produce a realistic dose-response but to explore the effect of changing ΔC~p~, *ΔS~a_immob~*, n and temperature on the trend in the predicted number, C.V~T~, of host CD4^+^ *T* cells with bound virus. Indeed, the overall conclusions of the model in terms of the effect of temperature on the number of CD4^+^ *T* cells with bound virus will still be representative and the interpretation applicable to all doses of viruses as there is no cooperation between viruses in this model ([@bib0021]). Furthermore, the levels of SIV in Rhesus monkey blood plasma were in the region of 2.1 × 10^8^ virions per ml ([@bib0028]) which is 2.1 × 10^5^ virions per mm^3^ and representative of the 10^5^ used for \[V~total~\] in the model here. C.V~T~ is calculated by multiplying F~cT~ by C~total~ ([Eq. (14)](#eqn0014){ref-type="disp-formula"}).

2.6. Case study 4: A large virus diameter such as for the HIV virion diminishes host cell binding at the higher temperatures of the human body through the large negative ΔS~a_immob~ {#sec0018}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

### 2.6.1. Estimation of ΔS~a_immob~ for a virus {#sec0019}

There are currently no data available on the magnitude of ΔS~a_immob~ which was first defined through development of a thermodynamic model ([@bib0022]). [@bib0050] reported a K~d_virus~ of 10^−15^ M for AIV where K~d_virus~ is the dissociation constant for virus from the host cell and is the inverse of K~a_virus_T~. According to [@bib0052] HIV virions bearing influenza A virus HA required 8 or 9 HA trimers for virus entry. This is equivalent to *n* = 24 to 27 HA monomers each of K~d_receptor~ = 10^−3^ M ([@bib0050]). It is not clear whether the 8 or 9 AIV HA trimers are required for cell binding or membrane fusion in [@bib0052]. However, if *n* = 24 HA monomers are required for AIV binding to the host cell to give a K~a_virus_T~ of 10^15^ M^−^ ^1^ then ΔS~a_immob~ equals −1091 J/mol/K from [Eq. (17)](#eqn0017){ref-type="disp-formula"} (derived in [@bib0022]). This is in the same order of magnitude as assumed for ΔS~a_immob~ on the basis of virus molecular weight ([@bib0022]). It must be emphasized that the estimate of 8 or 9 HA trimers in [@bib0052] is based on a number of assumptions that may not hold, for example whereas each infection of a cell is a quantal, all-or-nothing event, the infectivity of a virion could span a wide spectrum of propensities and each mathematical model could have different virological interpretations (see [@bib0031]). However, in the absence of any data for ΔS~a_immob~ the value of n from [@bib0052] at least provides a theoretical approach to estimate it from [Eq. (17)](#eqn0017){ref-type="disp-formula"} for this "proof of concept" model.

### 2.6.2. Effect of virus size on the magnitude of ΔS~a_immob~ {#sec0020}

It was shown previously ([@bib0022]) that ΔS~a_immob~ is the sum of the changes in translational entropy (ΔS~trans~) and rotational entropy (ΔS~rot~) of the whole virus on binding. According to [@bib0037] ΔS~trans~ ∝ ln(Mass) and ΔS~rot~ ∝ ln(I~x~ x I~y~ x I~z~) where I~x~, I~y~ and I~z~ are the moments of inertia about the three principle axes of rotation. Since mass, M, is proportional to the volume and *I* = Mr^2^ where r is the radius of the virus, it may be shown that the decrease in entropy on immobilisation (ΔS~a_immob~) of a spherical virus can be expressed as [Eq. (18)](#eqn0018){ref-type="disp-formula"}.

Examples of diameters for arboviruses are \~50 nm for WNV ([@bib0039]) and DENV, 66 nm for Eastern equine encephalitis virus ([@bib0026]) with BTV being slightly larger at 85 nm ([@bib0042]). In contrast, HIV is much larger with a mean diameter of 134 nm in the case of mature HIV virions containing a single core ([@bib0006]). The problem with [Eq. (18)](#eqn0018){ref-type="disp-formula"} is that proportionality constants in units of J/mol/K are needed probably based on R as in the Sackur-Tetrode equation and the natural logarithm terms should be dimensionless such that the units of radius cancel out. However for the purpose of representing the effect of increasing the radius of the virus on ΔS~a_immob~ [Eq. (18)](#eqn0018){ref-type="disp-formula"} is used with the virus radius in units of nm. Thus from [Eq. (18)](#eqn0018){ref-type="disp-formula"}, the magnitude of ΔS~a_immob~ for a virus of diameter 134 nm is 18.6% more negative than that for a virus of diameter 66 nm. To illustrate the effect of increasing virus size on the number of CD4^+^ *T* cells in 1 mm^3^ of blood with bound virus, C.V~T~ is calculated for the HIV model using values of ΔS~a_immob~ which decrease in steps of 18.6% from −240 J/mol/K (i.e. to −285 J/mol/K, −337 J/mol/K and −400 J/mol/K).

2.7. Case study 5: HIV attachment factors may partially overcome the unfavourable ΔS~a_immob~ and enhance specific virus binding through Env/CD4 interactions at human body temperature {#sec0021}
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

### 2.7.1. Modelling the effect of non-specific binding of HIV to host CD4^+^ T cells prior to specific Env:CD4 interaction {#sec0022}

The term ΔS~a_immob~ represents the decrease in entropy of the virus on going from a freely rotating entity to being immobilised in a specific orientation on the host cell surface through *n* = 3 specific Env:CD4 interactions. Thermodynamically this could be accomplished in two consecutive steps whereby the virus first binds non-specifically to attachment proteins on the host cell surface with an entropy change of ΔS~a_non_specific~, and then rolls into place driven by *n* = 3 specific Env:CD4 interactions resulting in a further entropy loss (ΔS~a_specific~) as the virus particle takes up a specific orientation ready for viral entry. In effect ΔS~a_immob~ is the sum of two components, namely ΔS~a_non_specific~ and ΔS~a_specific~ according to [Eq. (19)](#eqn0019){ref-type="disp-formula"}. It should be noted that non-specific binding to HIV attachment factors would not increase ΔS~a_immob~ to zero because there are multiple ways a virus could bind non-specifically compared to the one way in which it binds to the CD4 receptors through a specific interaction between Env and CD4, that is the ΔS~a_specific~ term is always negative i.e. \<0 J/mol/K and ΔS~a_non_specific~ is always less negative than ΔS~a_immob~.

Prior attachment through non-specific binding would realise the ΔS~a_non_specific~ loss before specific Env:CD4 binding so that specific binding involves the ΔS~a_specific~ term alone. The value of ΔS~a_immob~ is estimated to be −1091 J/mol/K (see above) and for the purpose of demonstration here ΔS~a_immob~ is replaced by ΔS~a_specific~ in [Eq. (11)](#eqn0011){ref-type="disp-formula"} which is set to values of −400, −337, −285 and −240 J/mol/K in effect representing the effect of prior non-specific binding eliminating ΔS~a_non_specific~ values of −691, −754, −806 and −851 J/mol/K respectively according to [Eq. (19)](#eqn0019){ref-type="disp-formula"}.

2.8. Case study 6: Increasing the number, n, of GP/Cr contacts with temperature to reproduce the data of [@bib0019] for binding of HIV Env-expressing cells to cells expressing CD4 {#sec0023}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Two outputs of the model are demonstrated. The first output builds on the model in Case study 5 with a ΔS~a_specific~ of −206 J/mol/K to accommodate prior non-specific binding to attachment factors having eliminated the ΔS~a_non_specific~ of \~−900 J/mol/K. The model assumes *n* = 3 Env:CD4 interactions where n in [Eq. (11)](#eqn0011){ref-type="disp-formula"} is increased from *n* = 1 to *n* = 3 with temperature between 25 °C and 27 °C ([Fig. 6](#fig0006){ref-type="fig"}a) to represent the increase in contacts reported by [@bib0019].

The second output attempts to include non-specific binding and also CCR5 co-receptor binding and a ΔS~a_immob~ of −1110 J/mol/K is used to represent the free virus binding (i.e. prior to non-specific binding). [@bib0032] demonstrated that approximately four to six CCR5 molecules assemble around the HIV virion to form a complex needed for infection. The model here assumes *n* = 2 non-specific Env interactions with attachment factors followed by *n* = 4 Env:CCR5 interactions according to [@bib0032] and finally *n* = 3 Env:CD4 interactions based on [@bib0004] to form a complex for binding with *n* = 9 contacts in total which increase from 1 to 9 with temperature as shown in [Fig. 6](#fig0006){ref-type="fig"}b. [@bib0015] estimated the K~d_receptor_T~ of interaction between CCR5 and HIV gp120 to be 4 × 10^−9^ M. This is remarkably similar to the K~d_receptor_T~ for the interaction between CD4 and HIV Env of 4.75 × 10^−9^ M at 37 °C ([Table 4](#tbl0004){ref-type="table"}) and the same values for ΔH~a_receptor_T0~ and ΔS~a_receptor_T0~ not only for the four HIV Env:CCR5 interactions but also for the two non-specific interactions are therefore used as for the three HIV Env:CD4 interactions in [Table 4](#tbl0004){ref-type="table"} with the reference temperature, T~0~ at 37 °C.

3. Results {#sec0024}
==========

3.1. Published data on ΔC~p~ for GP/Cr binding and other protein-protein interactions {#sec0025}
-------------------------------------------------------------------------------------

Published values of ΔC~p~ for protein/protein binding and for AIV HA binding to SA glycans vary in magnitude ([Table 3](#tbl0003){ref-type="table"}). For the binding of HIV gp120 to CD4 which is a protein-protein interaction, the magnitude of ΔH~a_receptor_T~ becomes more negative as the temperature increases i.e. ΔC~p~ is negative ([Fig. 1](#fig0001){ref-type="fig"}). Similarly, negative values of ΔC~p~ were reported for other protein-protein systems, namely the binding of E3 and E1 proteins, respectively, in the assembly of the enzyme pyruvate dehydrogenase ([@bib0029]), although with ΔC~p~ values less negative than that for HIV gp120:CD4 ([Table 3](#tbl0003){ref-type="table"}). In contrast for AIV HA binding to the SA glycan the magnitude of ΔC~p~ is not significantly different from zero with ΔH~a_receptor_T~ constant over the temperature range 15 °C to 25 °C at least for binding of both α2--3 and α2--6 sialyllactose ([Fig. 1](#fig0001){ref-type="fig"}).

3.2. Case study 1: The predicted effect of the magnitude of ΔC~p~ on the temperature dependence of DENV transmission by *Aedes albopictus* {#sec0026}
------------------------------------------------------------------------------------------------------------------------------------------

Values of K~a_virus_T~ predicted over the temperature range of 10 °C to 37 °C using different values of ΔC~p~ intercept at the reference temperature (T~0~) of 37 °C ([Fig. 2](#fig0002){ref-type="fig"}a) with K~a_virus\_~ *~T~* = 10^12^ M^−^ ^1^ as expected for *n* = 4 GP/Cr interactions each of K~d_receptor_T0~ of 10^−3^ M ([Eq. (17)](#eqn0017){ref-type="disp-formula"}). With ΔC~p~ = 0 kJ/mol/K as for AIV HA/SA, K~a_virus_T~ increases with decreasing temperature according to the Van\'t Hoff Isochore. In contrast with ΔC~p~ = −5.02 kJ/mol/K as for HIV gp120:CD4, K~a_virus_T~ peaks at 26 °C and decreases rapidly at lower temperatures.

For the simulated DENV/*Ae. albopictus* model used here, small negative values of ΔC~p~ (−2.0 kJ/mol/K to 0 kJ/mol/K) have little effect on the probability of transmission at low temperatures ([Fig. 2](#fig0002){ref-type="fig"}c,d). This is because in the model here with ΔC~p~ in the range of-2.0 kJ/mol/K to 0 kJ/mol/K, K~a_virus_T~ is high at \>10^14^ M^−^ ^1^ at low temperatures ([Fig. 2](#fig0002){ref-type="fig"}a) and thus C.V~T~ is little affected until higher temperatures ([Fig. 2](#fig0002){ref-type="fig"}b) at which K~a_virus_T~ falls below 10^14^ M^−^ ^1^ ([Fig. 2](#fig0002){ref-type="fig"}a). Large negative values of ΔC~p~ (−5.0 kJ/mol/K) cause C.V~T~ to peak rapidly falling at lower temperatures ([Fig. 2](#fig0002){ref-type="fig"}b). This has a large effect on the predicted probability of transmission at lower temperatures with p~transmissionT~ 44-fold lower at 10 °C ([Fig. 2](#fig0002){ref-type="fig"}d). It is interesting to note that ΔC~p~ has little effect on p~transmissionT~ over the range of temperature (23 °C to 32 °C) at which laboratory vector competence experiments ([@bib0035]) are typically conducted ([Fig. 2](#fig0002){ref-type="fig"}c).

3.3. Case study 2: The magnitude of ΔC~p~ could explain the temperature peak observed in the specific binding of WEEV to susceptible *Culex tarsalis* BBFs {#sec0027}
----------------------------------------------------------------------------------------------------------------------------------------------------------

With a ΔC~p~ = −3.0 kJ/mol/K the magnitude of K~a_virus_T~ between 0 and 40 °C is relatively constant compared to those with ΔC~p~ = 0 kJ/mol/K and −5.02 kJ/mol/K ([Fig. 3](#fig0003){ref-type="fig"}a) varying by only 40-fold and peaking at 1.62 × 13^13^ M^−^ ^1^ at 18 °C. However, this variation in K~a_virus_T~ between 10^12^ and 10^13^ M ^−^ ^1^ is optimal for affecting the number of midgut cells with bound virus ([Fig. 3](#fig0003){ref-type="fig"}b). This is because K~a_virus_T~ is high enough such that a significant proportion of midgut cells have bound virus over the 0 °C to 40 °C temperature range but not high enough to exceed the 10^14^ M^−^ ^1^ above which all the midgut cells are saturated with virus. The variation in C.V~T~ with temperature with ΔC~p~ = −3.0 kJ/mol/K shows some similarity to the percentage variation in the amount of WEEV bound to BBFs from susceptible *Culex tarsalis* mosquitoes as measured experimentally by [@bib0027] as represented by the symbols in [Fig. 3](#fig0003){ref-type="fig"}b. According to [@bib0027] the K~a_virus_T~ at 20 °C for WEEV binding to BBFs from susceptible *Culex tarsalis* mosquitoes is 2.2 × 10^11^ M^−^ ^1^. This is within two orders of magnitude of the value of 1.57 × 10^13^ M^−^ ^1^ predicted by the model here with ΔC~p~ = −3.0 kJ/mol/K ([Fig. 3](#fig0003){ref-type="fig"}a).

3.4. Case study 3: A large negative ΔC~p~ for a protein:protein GP/Cr system as represented by HIV gp120:CD4 diminishes host cell binding at higher temperature {#sec0028}
---------------------------------------------------------------------------------------------------------------------------------------------------------------

### 3.4.1. Reference temperature, T~0~, equals 37 °C {#sec0029}

K~a_virus_T~ values for HIV binding and C.V~T~ values for the number of CD4^+^ *T* cells in 1 mm^3^ of blood with bound HIV as a function of temperature are shown in [Fig. 4](#fig0004){ref-type="fig"}a and b respectively for different ΔC~p~ values with T~0~ = 37 °C. The K~a_virus_T~ and C.V~T~ values in [Fig. 4](#fig0004){ref-type="fig"}a and b respectively assume *n* = 3 Env:CD4 contacts with thermodynamic parameters in [Table 4](#tbl0004){ref-type="table"} and ΔS~a_immob~ = −400 J/mol/K. The large negative value of ΔC~p~ of −5.02 kJ/mol/K reported for gp120:CD4 ([Table 3](#tbl0003){ref-type="table"}) diminishes binding at higher temperatures compared to ΔC~p~ of 0 kJ/mol/K. Thus from [Fig. 4](#fig0004){ref-type="fig"}b, only half of the 1000 cells have bound virus at 12 °C with ΔC~p~ = −5.02 kJ/mol/K while with ΔC~p~ = 0 kJ/mol/K half the cells still have bound virus at a temperature of 6 °C higher (18 °C). With ΔC~p~ = −5.02 kJ/mol/K, C.V~T~ is \<1 cell (i.e. no virus bound) at 22 °C while with ΔC~p~ = 0 kJ/mol/K the slightly higher temperature of 24 °C is required to decrease C.V~T~ to \<1 cell ([Fig. 4](#fig0004){ref-type="fig"}b).

### 3.4.2. Effect of changing the reference temperature, T~0~, from 37 °C to 4 °C {#sec0030}

The three lines representing K~a_virus_T~ for different values of ΔC~p~ in [Fig. 4](#fig0004){ref-type="fig"}a intercept at 37 °C (T~0~) and would do for C.V~T~ in [Fig. 4](#fig0004){ref-type="fig"}b if extrapolated to 37 °C. To demonstrate how the magnitude of ΔC~p~ affects K~a_virus_T~ at temperatures of 37 °C representing mammalian body temperature, the reference temperature is set to 4 °C such that the three plots for K~a_virus_T~ intercept at 4 °C in [Fig. 4](#fig0004){ref-type="fig"}c with much lower K~a_virus_T~ values predicted at 37 °C with a large negative ΔC~p~ than for a system with ΔC~p~ = 0 kJ/mol/K. The effect of ΔC~p~ on the number of cells with bound virus at higher temperatures is considerable with C.V~T~ reduced to 1 cell at 22 °C with ΔC~p~ = −5.02 kJ/mol/K compared to 31 °C with ΔC~p~ = 0 kJ/mol/K ([Fig. 4](#fig0004){ref-type="fig"}d).

It should be noted that the dashed lines in [Fig. 4](#fig0004){ref-type="fig"}c and d are the same as those in [Fig. 4](#fig0004){ref-type="fig"}a and b respectively being based on experimental data for HIV gp120:CD4 ([Fig. 1](#fig0001){ref-type="fig"}). The purpose of the dotted and solid lines is merely to illustrate the effect of less negative ΔC~p~ increasing the binding at higher temperatures for the purpose of understanding.

3.5. Case study 4: A large virus diameter as for the HIV virion diminishes host cell binding at the higher temperature of the human body through the large negative ΔS~a_immob~ {#sec0031}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

From [Eq. (18)](#eqn0018){ref-type="disp-formula"}, ΔS~a_immob~ becomes more negative as the diameter of the virus increases. The value of K~a_virus_T~ decreases with increasing temperature in [Fig. 5](#fig0005){ref-type="fig"} a while more negative values of ΔS~a_immob~ merely shift each parallel curve to lower K~a_virus_T~ values as expected from [Eq. (17)](#eqn0017){ref-type="disp-formula"} such that K~a_virus_T~ falls below 10^14^ M^−^ ^1^ at progressively lower temperatures. Values of C.V~T~ with ΔS~a_immob~ decreasing from −240 J/mol/K to −400 J/mol/K in steps of 18.6% are plotted in [Fig. 5](#fig0005){ref-type="fig"}b and show that the number of cells with bound virus falls to \<1 at progressively lower temperature as ΔS~a_immob~ becomes more negative through increasing the virus diameter. The temperature at which C.V~T~ falls to \<1 is predicted to increase from 22 °C to 43 °C as ΔS~a_immob~ increases in magnitude from −400 J/mol/K to −240 J/mol/K. The conclusion from [Fig. 5](#fig0005){ref-type="fig"}a and b is that smaller viruses with less negative ΔS~a_immob~ bind more strongly at higher temperatures than larger viruses. Only with ΔS~a_immob~ as high as −240 J/mol/K representing smaller viruses do more than 30% of the 1000 cells have bound virus at the human body temperature of 37 °C according to the model in [Fig. 5](#fig0005){ref-type="fig"}b. This is shown in [Fig. 5](#fig0005){ref-type="fig"}c where nearly all the cells have bound virus at 10 °C irrespective of ΔS~a_immob~ while at higher temperatures fewer cells have bound virus as ΔS~a_immob~ becomes more negative.Fig. 5Predicted effect of ΔS~a_immob~ on the temperature sensitivity of a) K~a_virus_T~ and b) the number of host CD4^+^*T* cells, C.V~T~, with bound HIV virions in a system comprising C~total~ = 10^3^ CD4^+^ host *T* cells in a 1 mm^3^ vol of blood with a challenge dose of 10^5^ HIV virions. The values of ΔH~a_receptor_T0~ and ΔS~a_receptor_T0~ at T~0~ = 37 °C for specific HIV Env:CD4 binding are given in [Table 4](#tbl0004){ref-type="table"} with *n* = 3 Env:CD4 specific interactions and ΔC~p~ = −5.02 kJ/mol/K ([Table 3](#tbl0003){ref-type="table"}) for ΔS~a_immob~ = −400 J/mol/K (dashed line), −337 J/mol/K (dash-dotted line), −285 J/mol/K (dotted line) and −240 J/mol/K (solid line). c) Effect of ΔS~a_immob~ on C.V~T~ predicted at temperatures of 10 °C (dashed line), 22 °C (dash-dotted line), 30 °C (dotted line) and 37 °C (solid line) with symbols representing outputs from model. For case study 4, more negative values of ΔS~a_immob~ represent virions of increasing diameter. For case study 5, non-specific HIV attachment factor interactions prior to the specific HIV Env:CD4 interactions make ΔS~a_immob~ less negative through realising entropy loss of ΔS~a_non_specific~ in [Eq. (19)](#eqn0019){ref-type="disp-formula"} (see text).Fig. 5:

3.6. Case study 5: HIV attachment factors may partially overcome the unfavourable ΔS~a_immob~ and enhance specific virus binding through Env/CD4 interactions at human body temperature {#sec0032}
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

[Fig. 5](#fig0005){ref-type="fig"} can also be interpreted in terms of the effect of prior non-specific binding of HIV to attachment factors eliminating ΔS~a_non_specific~ values of −691, −754, −806 and −851 J/mol/K according to [Eq. (19)](#eqn0019){ref-type="disp-formula"} thus increasing ΔS~a_specific~ for specific Env:CD4 binding (as ΔS~a_immob~ in [Eq. (11)](#eqn0011){ref-type="disp-formula"}) from −400 J/mol/K to −240 J/mol/K. [Fig. 5](#fig0005){ref-type="fig"}b shows that the number of CD4^+^ *T* cells in a 1 mm^3^ vol of blood with bound HIV falls from 1000 to \<1 over a temperature range of \~10 °C. The temperature at which fewer than half the T cells in the 1 mm^3^ vol of blood have bound HIV virus increases with increasing ΔS~a_specific~ from 12.5 °C for ΔS~a_specific~ = −400 J/mol/K to 36.5 °C for ΔS~a_specific~ = −240 J/mol/K ([Fig. 5](#fig0005){ref-type="fig"}b). Indeed once the ΔS~a_specific~ is \>−200 J/mol/K, 98% of the 1000 T cells have bound HIV at 37 °C (not shown). With ΔS~a_specific~ \<−285 J/mol/K virus is not specifically bound to any of the 1000 T cells at temperatures above 37 °C. It is concluded that the effect of making ΔS~a_immob~ less unfavourable through prior non-specific binding taking some of the entropy loss enhances subsequent specific binding of HIV through Env:CD4 interactions at higher temperatures. [Fig. 5](#fig0005){ref-type="fig"}c shows that at 37 °C increasing ΔS~a_specific~ from −400 to −240 J/mol/K increases the number of CD4^+^ *T* cells with HIV bound through specific Env/CD4 interactions in a 1 mm^3^ vol of blood from 2 × 10^−6^ to 307. It should be noted that 2 × 10^−6^ cells in 1 mm^3^ is equivalent to 1 cell in 500 cm^3^ of blood.

3.7. Case study 6: Increasing the number, n, of GP/Cr contacts with temperature to reproduce the data of [@bib0019] for binding of HIV Env-expressing cells to cells expressing CD4 {#sec0033}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Cells expressing HIV Env on their surface can bind and fuse with cells expressing CD4 Cr ([@bib0019]). [@bib0019] reported a three to four fold increase in cell binding at temperatures above 25 °C with a substantial decrease in binding at temperatures above 37 °C ([Fig. 6](#fig0006){ref-type="fig"} ), the latter being predicted by the thermodynamic model in [Fig. 5](#fig0005){ref-type="fig"}b. [@bib0019] attribute the increase at 25 °C to the additional adhesion molecules which are brought into contact to increase the avidity of binding at higher temperatures. The thermodynamic model for HIV binding with ΔS~a_immob~ of −206 J/mol/K reproduces the increase in predicted C.V~T~ in [Fig. 6](#fig0006){ref-type="fig"}a by increasing n from 1 to 3 over the temperature range 25 °C and 27 °C to reflect the effect of temperature facilitating multiple HIV adhesion/binding sites due to increased membrane fluidity ([@bib0019]; [@bib0024]). Increasing n from 1 to 9 over the temperature range 19 °C and 27 °C gives a sharp increase in C.V~T~ at 26 °C ([Fig. 6](#fig0006){ref-type="fig"}b) with ΔS~a_immob~ of −1110 J/mol/K. The subsequent sharp fall in C.V~T~ at temperatures above 37 °C is due to the large negative magnitude of ΔS~a_immob~ (−206 J/mol/K in [Fig. 6](#fig0006){ref-type="fig"}a and -[1](#fig0001){ref-type="fig"}110 J/mol/K in [Fig. 6](#fig0006){ref-type="fig"}b) relative to n such that the diminished GP/Cr affinity at higher temperatures is not sufficient to maintain binding even with *n* = 9 GP/Cr interactions in [Fig. 6](#fig0006){ref-type="fig"}b. The decrease in GP/Cr binding affinity with temperature for HIV Env:CD4 is apparent from the K~a_virus_T~ values in [Fig. 5](#fig0005){ref-type="fig"}a and the increase in the values of K~d_receptor_T~ for the temperatures 4 °C, 25 °C and 37 °C in [Table 4](#tbl0004){ref-type="table"}.Fig. 6Experimental binding of HIV Env-expressing cells to cells expressing CD4 as reported by [@bib0019] increases three to four fold at 25 °C (cross). The number, C.V~T~, of CD4^+^*T* cells with bound HIV virions per mm^3^ blood predicted by the thermodynamic model (circle) using [Eq. (11)](#eqn0011){ref-type="disp-formula"} with the number, n, of GP/Cr contacts increasing according to the dotted line with temperature in a) from 1 to 3 between 25 and 27 °C; and in b) from 1 to 9 between 19 °C and 27 °C. The values of ΔH~a_receptor_T0~ and ΔS~a_receptor_T0~ at T~0~ = 37 °C for non-specific attachment factor binding and for HIV Env:CCR5 co-receptor binding are as those for specific HIV Env:CD4 binding in [Table 4](#tbl0004){ref-type="table"} with ΔC~p~ = −5.02 kJ/mol/K ([Table 3](#tbl0003){ref-type="table"}). ΔS~a_immob~ = *a*) −206 J/mol/K to represent prior elimination of ΔS~a_non_specific~ through binding of virus through non-specific attachment; and b) −1,110 J/mol/K to represent free virus binding.Fig. 6:

4. Discussion {#sec0034}
=============

Previously a thermodynamic model for the effect of temperature on arthropod vector competence was developed ([@bib0022]) based on the parameters ΔH~a_receptor_T~, ΔS~a_receptor_T~, ΔS~a_immob~ and n, together with the kinetic parameters, p~complete283~ and E~A~ ([Table 2](#tbl0002){ref-type="table"}). This paper furthers that model by allowing the change in heat capacity, ΔC~p~, on GP/Cr binding to be included. This is important because it defines the effect of temperature on ΔH~a_receptor_T~ ([Eq. (4)](#eqn0004){ref-type="disp-formula"}) and ΔS~a_receptor_T~ ([Eq. (6)](#eqn0006){ref-type="disp-formula"}) and hence K~a_virus_T~. Of potentially greater importance, however, is the parameter ΔS~a_immob~ first formally identified in the thermodynamic analysis of virus binding ([@bib0022]). Thus it is proposed here that the value of ΔS~a_immob~ is not only important in explaining the observation that dsDNA viruses infecting warmer hosts are generally smaller in volume than those infecting colder hosts ([@bib0044]) but also may contribute to explaining the need for attachment factors to allow binding of a large virus such as HIV at the relatively high human body temperature of 37 °C. This has implications for the design of novel antiviral therapies. The mechanistic model developed here for HIV goes as far as cell binding and viral membrane fusion ([@bib0025]) could be added as the next stage to complete the cell entry process.

4.1. Justification of assumptions for ΔS~a_immob~ {#sec0035}
-------------------------------------------------

Calculations using [Eq. (17)](#eqn0017){ref-type="disp-formula"} on the basis of limited available data suggest ΔS~a_immob~ \~ −1100 J/mol/K for HIV although it is acknowledged above that there is considerable uncertainty in the absence of definitive experimental data. It is possible that statistical thermodynamics approaches analogous to the Sackur-Tetrode equation for the entropy of a gas may be developed to estimate ΔS~a_immob~ theoretically. The large size of the HIV virion (134 nm mean diameter) compared to a typical arbovirus (50 to 70 nm diameter) is consistent with a more negative value of ΔS~a_immob~ providing justification for the more negative ΔS~a_immob~ values used here for the HIV models in [Fig. 4](#fig0004){ref-type="fig"}, [Fig. 5](#fig0005){ref-type="fig"}, [Fig. 6](#fig0006){ref-type="fig"} compared to that used for the arbovirus models in [Figs. 2](#fig0002){ref-type="fig"} and [3](#fig0003){ref-type="fig"}.

4.2. Interpretation of figures {#sec0036}
------------------------------

[Fig. 2](#fig0002){ref-type="fig"}, [Fig. 3](#fig0003){ref-type="fig"}, [Fig. 4](#fig0004){ref-type="fig"}, [Fig. 5](#fig0005){ref-type="fig"} show the variation of K~a_virus_T~ and C.V~T~ with temperature as predicted by models assuming C~total~ = 10^3^ host cells in a 10^−6^ dm^3^ volume (i.e. mosquito midgut or human blood sample) challenged with V~total~ = 10^5^ virions. Previously it was shown that if K~a_virus\_~ *~T~* \> \~10^14^ M^−^ ^1^ then nearly all the host cells have bound virus at such a high virus dose ([@bib0021]; [@bib0022]). Thus the K~a_virus_T~ plots and corresponding C.V~T~ plots are best interpreted in terms of the temperature ranges over which K~a_virus\_~ *~T~* \< \~10^14^ M^−^ ^1^.

4.3. The importance of negligible ΔC~p~ for low temperature arbovirus transmission {#sec0037}
----------------------------------------------------------------------------------

For the arbovirus models in [Figs. 2](#fig0002){ref-type="fig"} and [3](#fig0003){ref-type="fig"}, the main conclusion regarding the change in heat capacity on GP/Cr binding is that as ΔC~p~ becomes more negative so a peak temperature for K~a_virus_T~ becomes apparent such that binding affinity falls at lower and higher temperatures, directly affecting C.V~T~ when K~a_virus_T~ falls below 10^14^ M^−^ ^1^. Values of ΔC~p~ from 0 to \~−2.0 kJ/mol/K have relatively little impact on the temperature sensitivity of the number, C.V~T~, of mosquito midgut cells with bound virus ([Fig. 2](#fig0002){ref-type="fig"}b), while intermediate values of ΔC~p~ of \~−3.0 kJ/mol/K give a peak binding at a temperature of \~20 °C as observed experimentally for WEEV binding to BBFs from susceptible mosquito midguts in [Fig. 3](#fig0003){ref-type="fig"}b. More negative values of ΔC~p~ at −5.0 kJ/mol/K greatly diminish arbovirus binding affinity at temperatures below \~20 °C ([Fig. 2](#fig0002){ref-type="fig"}b) which in turn diminishes the transmission efficiency of the arbovirus at temperatures below 20 °C compared to GP/Cr systems with ΔC~p~ in the range of −2.0 to 0 kJ/mol/K ([Fig. 2](#fig0002){ref-type="fig"}d). In evolutionary terms, to optimise arbovirus infectivity with *n* = 4 GP/Cr interactions over a range of temperatures, GP/Cr interactions with small ΔC~p~ would be selected as for AIV HA/SA binding ([Table 3](#tbl0003){ref-type="table"}). It is proposed here that to maintain some transmission efficiency at lower temperatures, arboviruses may use SA binding interactions as shown for BTV coat protein VP2 ([@bib0054]) for which ΔC~p~ may approximate 0 kJ/mol/K as in the case of AIV HA/SA ([Table 3](#tbl0003){ref-type="table"}). This would facilitate arboviruses' expanding their range into temperate regions of the world with climate change.

### 4.3.1. The value of ΔC~p~ does not affect arbovirus binding to arthropod midguts at higher temperatures {#sec0038}

With the reference temperature of T~0~ = 37 °C, C.V~T~ falls rapidly at temperatures above 20 °C in the arbovirus model here with *n* = 4 GP/Cr interactions irrespective of the magnitude of ΔC~p~ ([Fig. 2](#fig0002){ref-type="fig"}b) as the K~a_virus_T~ values fall below 10^14^ M ^−^ ^1^ and converge at 10^12^ M ^−^ ^1^ at 37 °C ([Fig. 2](#fig0002){ref-type="fig"}a). This fall is observed experimentally as the temperature is increased from 20 °C to 40 °C ([Fig. 3](#fig0003){ref-type="fig"}b) for WEEV binding to BBFs from susceptible mosquito midguts as reported by [@bib0027].

4.4. The large negative ΔC~p~ for HIV gp120:CD4 diminishes binding at human body temperature in the HIV model {#sec0039}
-------------------------------------------------------------------------------------------------------------

The ΔC~p~ for HIV gp120:CD4 binding is well documented unlike that for arbovirus binding and the values of ΔH~a_receptor_T~ have been reported over the temperature range of 12 °C to 44 °C ([Fig. 1](#fig0001){ref-type="fig"}). The results with varying ΔC~p~ in [Fig. 4](#fig0004){ref-type="fig"} are therefore hypothetical but illustrate how the large negative ΔC~p~ for the HIV Env:CD4 interaction diminishes binding at the higher temperatures of mammals and birds compared to a system such as HA/SA for which ΔC~p~ = 0 kJ/mol/K. Thus, a less negative ΔC~p~ increases the number of cells with bound virus at higher temperatures, albeit more markedly for the reference temperature T~0~ = 4 °C ([Fig. 4](#fig0004){ref-type="fig"}d) than for T~0~ = 37 °C ([Fig. 4](#fig0004){ref-type="fig"}b). In the absence of data for ΔC~p~ for HIV Env:CD4 binding, the value for the gp120 monomer:CD4 interaction is used for the HIV models in [Fig. 4](#fig0004){ref-type="fig"}, [Fig. 5](#fig0005){ref-type="fig"}, [Fig. 6](#fig0006){ref-type="fig"}. Evidence for a large negative ΔC~p~ for HIV Env:CD4 binding is that cryo-EM demonstrates considerable conformational shifts ([@bib0034]).

4.5. ΔS~a_immob~ as a repulsive force in virus binding {#sec0040}
------------------------------------------------------

A negative value of ΔS~a_immob~ presents a repulsive force between the virus and the host cell in effect preventing virus binding and with *n* = 0 GP/Cr contacts, K~a_virus_T~ is \< 1 M^−^ ^1^ according to [Eq. (17)](#eqn0017){ref-type="disp-formula"} ([@bib0022]). Increasing the value of n is one way for the virus to overcome a large negative value of ΔS~a_immob~ ([@bib0022]). Thus 15 to 18 GP/Cr contacts of K~d_receptor_T0~ = 10^−3^ M (37 °C) were sufficient to overcome a ΔS~a_immob~ of −750 J/mol/K such that K~a_virus\_~ *~T~* \> 10^14^ M^−^ ^1^ (Fig. 3 of [@bib0022]). This is apparent from [Fig. 6](#fig0006){ref-type="fig"}a where *n* = 3 GP/Cr contacts can overcome a ΔS~a_immob~ of −206 J/mol/K while *n* = 9 GP/Cr contacts are required to overcome the more negative ΔS~a_immob~ of −1110 J/mol/K in [Fig. 6](#fig0006){ref-type="fig"}b.

4.6. A less negative ΔS~a_immob~ maintains virus binding at higher temperatures {#sec0041}
-------------------------------------------------------------------------------

Even for ΔS~a_immob~ = 0 J/mol/K as in [Figs. 2](#fig0002){ref-type="fig"}a and [3](#fig0003){ref-type="fig"}a, the magnitude of K~a_virus_T~ decreases with increasing temperature (albeit after a peak in the case of ΔC~p~ \< −2.0 kJ/mol/K). This is due to the reduced affinity of the enthalpy-driven GP/Cr interactions at higher temperatures. Making ΔS~a_immob~ more negative shifts the K~a_virus_T~ curve to lower values ([Fig. 5](#fig0005){ref-type="fig"}a) thus exacerbating the effect of higher temperature on reducing binding. As K~a_virus_T~ falls below 10^14^ M ^−^ ^1^ at higher temperatures, so C.V~T~ falls ([Fig. 5](#fig0005){ref-type="fig"}b). The magnitude of ΔS~a_immob~ merely positions the C.V~T~ curve relative to the temperature scale with less negative values of ΔS~a_immob~ shifting the curve to higher temperatures ([Fig. 5](#fig0005){ref-type="fig"}b) such that high C.V~T~ values are maintained at progressively higher temperatures as ΔS~a_immob~ becomes less negative ([Fig. 5](#fig0005){ref-type="fig"}c).

4.7. Balancing opposing constraints at mammalian host temperatures {#sec0042}
------------------------------------------------------------------

The thermodynamic model here suggests that a large negative ΔC~p~ for HIV Env:CD4 diminishes binding at higher temperatures. However, there may be molecular constraints such that a large negative ΔC~p~ value is a direct consequence of a molecular mechanism involving a large conformational change that serves a purpose for cell entry/fusion ([@bib0025]) such that a negligible ΔC~p~ value may not be achievable. Furthermore, a large negative ΔS~a_immob~ imposes additional constraints on virus binding at higher temperatures exacerbating the reduced strength of the enthalpy-driven GP/Cr interactions at higher temperatures. Therefore other mechanisms may be needed by the virus to achieve binding at 37 °C. These could include more GP/Cr contacts at higher temperature ([@bib0019]; [@bib0024]). An alternative strategy evolved by viruses could be to make ΔS~a_immob~ itself less negative such that virus binding is maintained at the higher body temperatures of mammals and birds. Two possible evolutionary strategies are suggested here which could make ΔS~a_immob~ less negative. The first is decreasing the size of the virus and the second is the use of non-specific attachment factors to randomly trap the virus on the cell surface prior to specific GP/Cr binding.

4.8. Small virus size makes ΔS~a_immob~ less negative thus maintaining binding at higher temperatures {#sec0043}
-----------------------------------------------------------------------------------------------------

Decreasing the size of a virus makes ΔS~a_immob~ less negative ([Eq. (18)](#eqn0018){ref-type="disp-formula"}) such that smaller viruses bind more strongly at the higher temperatures of mammals and birds ([Fig. 5](#fig0005){ref-type="fig"}). It is suggested that binding to cells at the higher temperatures of avian and mammalian hosts selects for viruses of smaller diameter through a less negative ΔS~a_immob~. This could explain the decrease in volume of viruses with increasing host/environment temperature as reported by [@bib0044] for dsDNA viruses. Thus the average diameters of dsDNA viruses decreased from 182 nm at a host/environment temperature of 10 °C down to 74 nm at 37 °C according to the best fit line of [@bib0044] suggesting the HIV virion at 134 nm mean diameter is almost double the size for a virus infecting at avian/mammalian host temperature. It is interesting to note that thermophilic bacteria adapted to high temperature may be subject to selection favouring smaller cell size. This may aid attachment to biofilms which provide some protection against temperature stress.

4.9. The importance of prior non-specific binding in taking some of the entropy loss in ΔS~a_immob~ {#sec0044}
---------------------------------------------------------------------------------------------------

It is proposed here that by taking the entropy loss *ΔS~a_non_specific~* in ΔS~a_immob~ that non-specific binding to attachment factors facilitates subsequent specific HIV Env binding to CD4 receptors on the host CD4^+^ *T* cell at human body temperature. Thus the shift in the K~a_virus_T~ curve to higher values with a less negative ΔS~a_immob~ in [Fig. 5](#fig0005){ref-type="fig"}a is consistent with HIV attachment factors augmenting infection ([@bib0049]). Indeed with *n* = 3 Env:CD4 contacts, significant binding of HIV to host cells is only achieved at 37 °C if ΔS~a_immob~ is increased to \> −280 J/mol/K ([Fig. 5](#fig0005){ref-type="fig"}c). ΔS~a_immob~ is estimated here to be −1091 J/mol/K for HIV. Thus the prior non-specific binding of HIV would need to realise a *ΔS~a_non_specific~* of −810 J/mol/K for subsequent effective Env:CD4 binding at human body temperature according to the model such that *ΔS~a_non_specific~* in [Eq. (19)](#eqn0019){ref-type="disp-formula"} takes \~75% of the entropy loss in ΔS~a_immob~. [@bib0049] also report that HIV attachment factors are not essential. Again this is consistent with the model here when it is noted that the C.V~T~ value of \<1 CD4^+^ *T* cell with bound virus in [Fig. 5](#fig0005){ref-type="fig"}b is not a threshold and merely represents 1 mm^3^ of blood. Thus with ΔS~a_immob~ = −348 J/mol/K, C.V~T~ = 1 × 10^−3^ at 37 °C ([Fig. 5](#fig0005){ref-type="fig"}c). This represents one CD4^+^ *T* cell with bound HIV in 1000 × 1 mm^3^ vol of blood, i.e. in 1 cm^3^ of blood. Decreasing ΔS~a_immob~ further to −405 J/mol/K gives C.V~T~ = 1 × 10^−6^ at 37 °C representing one CD4^+^ *T* cell with bound HIV in 1 litre of blood.

4.10. Making ΔS~a_immob~ more negative as a strategy for development of antiviral therapeutics {#sec0045}
----------------------------------------------------------------------------------------------

The model here suggests human body temperature may be a constraint on HIV binding (due to the large negative values of both ΔC~p~ and ΔS~a_immob~) in effect exposing a potential weakness in the HIV infection strategy which could be exploited for antiviral therapy. Figure 9 of [@bib0001] shows a herpes simplex virus type 2 (HSV-2) bound to a tetrahedral nanoparticle of zinc oxide (ZnO) called a zinc oxide tetrapod (ZnOT). The mechanism behind the ability of ZnOTs to prevent, neutralize or reduce HSV-2 infection relies on their ability to bind the HSV-2 virions ([@bib0001]). The ZnOT being some 40 µm in size is much larger than the attached virion which could still attach to a host cell surface in terms of spatial considerations. However, the magnitude of ΔS~a_immob~ for an HSV-2 virion bound to a ZnOT nanoparticle would be very large and negative, indeed much more negative than for ΔS~a_immob~ for a free HSV-2 virion. Thus according to [Fig. 5](#fig0005){ref-type="fig"}c, binding of HSV-2/ZnOT to host cells would be greatly diminished particularly at the human body temperature due to the very large negative ΔS~a_immob~. Although ΔS~a_immob~ changes logarithmically (i.e. slowly) with virus size according to Eq. (18), the number, C.V~T~, of cells with bound virus is very sensitive to changes in ΔS~a_immob~ at 37 °C (Fig. 5c). It is proposed that antiviral research should take into account and even focus on making the magnitude of ΔS~a_immob~ more negative in addition to looking at conventional approaches to block the GP/Cr interaction. The advantage of focusing on ΔS~a_immob~ is that only one ZnOT nanoparticle has to bind to a virus to markedly affect ΔS~a_immob~, while a large proportion of the GP molecules on the virus have to be bound with inhibitors, including neutralising antibodies, to block virus binding ([@bib0031]) and hence eliminate ΔH~a_receptor_T0~ in [Eq. (11)](#eqn0011){ref-type="disp-formula"}. The temperature dependence of virus diffusion in mucus ([@bib0017]) could also be considered not only in mechanistic dose-response models for viral infection at mucosal epithelial membranes in the intestine ([@bib0021]) but also in terms of therapeutics when combined with the thermodynamic approach developed here. Normal, acidic cervicovaginal mucus greatly hinders the movement of virions of HSV and HIV, whereas mucus that is neutralized by semen provides a much less effective barrier against the same virions ([@bib0017]). Thus binding of the HSV or HIV virion to a ZnOT particle may not only decrease its diffusion coefficient in mucus but also make the magnitude of ΔS~a_immob~ more negative hence reducing the binding affinity of those virions which do make it through the mucus to the epithelial cell surface at human body temperature.

4.11. Validation of the HIV model {#sec0046}
---------------------------------

It is assumed for the purpose of the "proof of concept" model here that the thermodynamic parameters for the HIV gp120 monomer:CD4 interaction in [@bib0041] can be used for HIV Env trimer binding to a single CD4 in the absence of data. Although the K~d_receptor_T~ value for the Env trimer:CD4 interaction (1.4 × 10^−9^ M, [@bib0010]) is 15-fold higher than that for the gp120 monomer:CD4 interaction (0.9 × 10^−10^ M, [Table 4](#tbl0004){ref-type="table"}) at 25 °C, this is close enough to support using the gp120 monomer:CD4 data, particularly as K~d_receptor_T~ values for the gp120 monomer:CD4 interaction vary nine-fold between two HIV strains (see above).

The predicted values of K~a_virus_T~ increase with decreasing temperature according the HIV model in [Fig. 5](#fig0005){ref-type="fig"}a. This is unexpected on the basis of the ΔH~a_receptor_T~ values reported by [@bib0041] for gp120:CD4 which become less negative with decreasing temperature ([Fig. 1](#fig0001){ref-type="fig"}). However, according to [Eq. (6)](#eqn0006){ref-type="disp-formula"} the predicted ΔS~a_receptor_T~ term becomes more favourable (less negative) with decreasing temperature and it is therefore the entropy term that facilitates the tighter binding of gp120 to CD4 at lower temperatures. Unfortunately [@bib0041] only give the full range of values for ΔH~a_receptor_T~ ([Fig. 1](#fig0001){ref-type="fig"}) with no data for ΔS~a_receptor_T~ over the range of temperature. However, [@bib0041] do give some graphical data from which ΔS~a_receptor_T~ at 25 °C can be estimated and it is reassuring this ΔS~a_receptor_T~ is much less negative at −473 J/mol/K than that of −691 J/mol/K measured at 37 °C and furthermore is actually less negative than the value of −492.8 J/mol/K predicted for 25 °C by [Eq. (6)](#eqn0006){ref-type="disp-formula"} ([Table 4](#tbl0004){ref-type="table"}) and used in the model in [Fig. 5](#fig0005){ref-type="fig"}. This is strong experimental evidence that warming to 37 °C and above does indeed give a significant reduction in the binding affinity of Env to CD4 as borne out by the 52-fold increase in the K~d_receptor_T~ value for gp120:CD4 on warming from 25 °C to 37 °C as calculated from the actual data of [@bib0041] ([Table 4](#tbl0004){ref-type="table"}). Furthermore it suggests that the actual increase in K~a_virus_T~ on cooling from 37 °C down to 25 °C may be greater than that predicted by the model in [Fig. 5](#fig0005){ref-type="fig"}a. The decrease in binding affinity with increasing temperature for HIV Env:CD4 is also supported by experimental data of [@bib0038] which showed that soluble CD4 dissociated from HIV virions at temperatures above 35 °C. Similarly [@bib0015] demonstrated that gp120 bound to CD4^+^ *T* cells began to dissociate at temperatures above 45 °C. The data of [@bib0019] in [Fig. 6](#fig0006){ref-type="fig"} offer further validation of the model in that the binding of HIV Env-expressing cells to cells expressing CD4 decreases substantially at 37 °C as predicted by the model. The Env trimer is stable up to at least 60 °C ([@bib0010]) suggesting it is not denaturation of the Env trimer itself that is responsible for the decreased binding at higher temperatures. However, care has to be taken in using [Eqs. (4)](#eqn0004){ref-type="disp-formula"} and [(6)](#eqn0006){ref-type="disp-formula"} to predict ΔH~a_receptor_T~ and ΔS~a_receptor_T~ respectively down to very low temperatures. Thus although the predicted value of K~d_receptor_T~ for gp120:CD4 at 4 °C is 3700-fold lower than that at 37 °C ([Table 4](#tbl0004){ref-type="table"}), [@bib0019] cite some studies which suggested weaker binding of soluble CD4 to HIV virions at 4 °C compared to 37 °C. Without actual binding data for HIV over the full temperature range, it cannot be ruled out that K~a_virus_T~ does not exhibit a peak with temperature as for the WEEV binding in [Fig. 3](#fig0003){ref-type="fig"}b. Indeed, binding of ^125^I-labelled gp120 to T cells peaked at 16 °C with binding at 4 °C much lower than that at 37 °C ([@bib0019]). The observed increase between 4 °C and 16 °C is unlikely to be due to increased fluidity of the membrane allowing recruitment of more CD4 molecules because unlike the virus, each gp120 only binds a single Cr molecule. [@bib0014] showed that the activation energy for binding of soluble CD4 to cells expressing HIV Env changed at 18 °C suggesting 18 °C is a transition temperature. This could explain the peak in binding of gp120 at 16 °C reported by [@bib0019]. Thus extrapolation of ΔH~a_receptor_T~ and ΔS~a_receptor_T~ through [Eqs. (4)](#eqn0004){ref-type="disp-formula"} and [(6)](#eqn0006){ref-type="disp-formula"}, respectively to temperatures below 18 °C may not be justified in the case of HIV binding.

It should be remembered that HIV only infects humans at 37 °C and therefore the lower temperature predictions are more of academic interest, although temperature trends may give an insight into weaknesses in the HIV infection strategy as suggested here. It is only the 37 °C line in [Fig. 5](#fig0005){ref-type="fig"}c which is important for HIV and it is reassuring to note that this is based on actual experimental data for gp120 monomer:CD4 binding measured at that temperature. The lower temperature lines in [Fig. 5](#fig0005){ref-type="fig"}c are of more general interest, for example in explaining the observed relationship ([@bib0044]) between larger virus volume and lower host temperature.

4.12. Variation between virions in an exposure dose {#sec0047}
---------------------------------------------------

Individual virions of the same virus may vary both in size ([@bib0006]) and in the case of some RNA viruses in the actual base sequence of the genome giving a spectrum of mutants. The infection process may represent a bottleneck such that only one or two viral variants in the exposure dose successfully establish infection ([@bib0007]). Thus in the case of norovirus, only minor variants at frequencies as low as 0.01% were successfully transmitted to establish a new infection ([@bib0008]). The work here suggests that the actual size of the virion itself may present an additional constraint particularly at mammalian body temperatures. Thus although the average diameter for HIV virions with a single core is 134 nm, individual virions display a broad range of diameters extending from 120 to 200 nm with a skewed distribution ([@bib0006]). Furthermore while the majority of HIV virions contained a single core, almost a third contained two or more cores. The mean diameter of the HIV virions containing a single core (134 ± 11 nm, *n* = 89) was significantly smaller than the mean diameter of virions containing two cores (158 ± 16 nm, *n* = 43) ([@bib0006]). Thus the magnitude of ΔS~a_immob~ may vary between individual HIV virions within the same exposure dose. The key conclusion from [Fig. 5](#fig0005){ref-type="fig"}c is that the number of CD4^+^ *T* cells with bound virus is highly sensitive to the magnitude of ΔS~a_immob~ with just a 4.5% increase in the magnitude of ΔS~a_immob~ from --290 to --277 J/mol/K for example increasing C.V~T~ by five-fold from 1 to 5 CD4^+^ *T* cells per mm^3^ of blood at 37 °C. Thus smaller diameter viruses in a challenge does may have an advantage in binding and hence initiating infection at mammalian body temperatures. This also raises the question of the magnitude of ΔS~a_immob~ for an aggregate containing several virions of the same virus and in the case of EBOV, for the long filaments linking multiple genome copies ([@bib0002]). It has previously been proposed that fusing multiple genome copies into the same filament in the case of EBOV takes some of the entropy loss for ΔS~a_immob~ prior to binding to the cell surface ([@bib0020]) such that aggregation can be viewed as a cooperative effect in the infection process. The effect of aggregation and virus size on the magnitude of ΔS~a_immob~ according to [Eq. (18)](#eqn0018){ref-type="disp-formula"} needs to be investigated and understood to further the work here.

5. Conclusion {#sec0048}
=============

From a thermodynamic perspective, the affinity of virus binding to a host cell is greatly decreased at the higher body temperatures of mammals and birds such that temperature can be considered a constraint to be overcome. The relationship between binding affinity and temperature can be markedly affected by the change in heat capacity (ΔC~p~) on virus binding through its effect on the enthalpy and entropy of the GP/Cr interaction. Specifically large negative values of ΔC~p~ reduce binding at both low and high temperatures giving a peak binding at a medium temperature as has been observed experimentally in binding of WEEV to mosquito midguts. Very large negative values of ΔC~p~ for protein/protein GP/Cr interactions are predicted to diminish arbovirus transmission at low temperatures compared to the HA/SA glycan interaction for which ΔC~p~ is negligible. Thus selecting for SA glycan interactions as reported for BTV binding may be a mechanism to allow transmission at the lower temperatures experienced by arboviruses infecting arthropods in temperate regions of the world.

The magnitude of ΔS~a_immob~ is currently unknown but is predicted to be large and negative and to be more negative for larger viruses such as HIV (mean diameter 134 nm) compared to the smaller arboviruses (diameter 50 to 70 nm). Small virion diameter through a less negative ΔS~a_immob~, favours virus binding at higher temperatures giving smaller viruses a selective advantage for infecting hosts at the higher body temperatures of mammals and birds. This is in agreement with the published observational findings that virus volume decreases with increasing host temperature in the case of dsDNA viruses.

In the case of HIV, the unfavourable effect at human body temperature of the large negative ΔS~a_immob~ value due to the large size of the virus may be overcome by non-specific binding. It is proposed here that non-specific binding of HIV as the virus first randomly attaches to a host CD4^+^ *T* cell surface takes a large proportion (represented by ΔS~a_non_specific~) of the entropy loss of ΔS~a_immob~ such that HIV can then bind specifically through Env:CD4 interactions at the relatively high temperature of the human body. The randomly attached virus "rolls into place" driven by *n* = 3 specific Env:CD4 interactions resulting in a further entropy loss (ΔS~a_specific~) as the virus particle takes up a specific orientation ready for viral entry. Non-specific attachment factors are all the more important for a GP/Cr system such as the HIV Env:CD4 interaction for which ΔC~p~ is large and negative and diminishes binding at higher temperatures.

It is concluded that experimental data on ΔS~a_immob~ should be obtained and antiviral therapeutic strategies, for example using zinc oxide nanoparticles for herpes simplex virus or neutralising antibodies to block virus binding, should focus not only on blocking the Cr-binding sites on the GP molecules themselves but also on targeting ΔS~a_immob~ by increasing the size of the virus itself and so minimising host cell binding affinity at human body temperatures according to the model here. Bacterial cells are larger than viruses and ΔS~a_immob~ would be expected to be more negative. Targeting ΔS~a_immob~ may also have application as an alternative approach to antibiotics for bacterial pathogens when bacterial pathogenesis depends on attachment to cells. However, it should be noted that ΔS~a_immob~ decreases logarithmically (i.e. slowly) with increasing size which may limit the practicability to bacteria.
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[^1]: Analysis of the data of [@bib0018] by using their reported ΔG/TΔS values and K~d_receptor_T~ values confirms that ΔH~a_receptor_T~ does not change with temperature with regression coefficients not being significantly different to zero (*P* \>0.19) for binding of α2--3 and α2--6 sialyllactose to AIV HA monomer.

[^2]: From [@bib0041] for full length gp120 (reported as −63 kcal/mol) at 37 °C.

[^3]: Calculated from --TΔS = +214.22 kJ/mol for full length gp120 (reported as +51.2 kcal/mol by [@bib0041]) at 37°C.

[^4]: Calculated from [Eq. (4)](#eqn0004){ref-type="disp-formula"} using ΔC~p~ = −5.02 kJ/mol/K ([Table 3](#tbl0003){ref-type="table"}) with T~0~ = 310 K (37 °C).

[^5]: Calculated from [Eq. (6)](#eqn0006){ref-type="disp-formula"} using ΔC~p~ = −5.02 kJ/mol/K ([Table 3](#tbl0003){ref-type="table"}) with T~0~ = 310 K (37 °C).

[^6]: Estimated from values for ΔH~a_receptor_T~ and -TΔS~a_receptor_T~ presented in Fig. 4 of [@bib0041] for gp120 binding to CD4 at 25 °C.

[^7]: In good agreement with ΔS~a_receptor_T~ value at *T* = 298 K (25 °C) of −492.8 J/mol/K as calculated from [Eq. (6)](#eqn0006){ref-type="disp-formula"} using ΔC~p~ = −5.02 kJ/mol/K ([Table 3](#tbl0003){ref-type="table"}) with T~0~ = 310 K (37 °C) and ΔS~a_receptor_T0~ = −691.04 J/mol/K (see b).
